Ikoma, Japan – Antibodies (immunoglobulins) are Y-shaped proteins that recognize and neutralize specific pathogens. Their ability to target specific molecules or cells has made them promising ...
Bispecific antibodies (BsAb) were first approved in 2014. Since then, a total of 19 have been approved globally, and approximately 250 BsAbs are being developed by some 180 companies, according to a ...
On June 12th, 2023 local time, Sanyou Biopharmaceuticals Co., Ltd. officially announced the launch of "Sanyou Super Trillion Common Light Chain Antibody Discovery Platform" (the "platform"). As one of ...
Single B cell platforms have emerged as powerful tools for antibody discovery, enabling the rapid isolation and screening of ...
Audio player for the podcast episode: AI & Antibodies mini-series - An artificial approach to humanization. Use the embedded player controls to play, pause, and adjust volume. Charlotte takes us ...
Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results